naltrexone and Experimental Mammary Neoplasms

naltrexone has been researched along with Experimental Mammary Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aylsworth, CF; Hodson, CA; Meites, J1
Abou-Issa, H; Tejwani, GA1
Gienapp, IE; Gudehithlu, KP; Hanissian, SH; Malarkey, WB; Tejwani, GA; Whitacre, CC1

Other Studies

3 other study(ies) available for naltrexone and Experimental Mammary Neoplasms

ArticleYear
Opiate antagonists can inhibit mammary tumor growth in rats.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1979, Volume: 161, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Endorphins; Female; Mammary Neoplasms, Experimental; Naloxone; Naltrexone; Rats

1979
Antitumor activity of naltrexone and correlation with steroid hormone receptors.
    Biochemical and biophysical research communications, 1991, Mar-15, Volume: 175, Issue:2

    Topics: Adenocarcinoma; Animals; Body Weight; Endorphins; Female; Mammary Neoplasms, Experimental; Naltrexone; Rats; Receptors, Estrogen; Receptors, Opioid; Receptors, Progesterone

1991
Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone.
    Carcinogenesis, 1991, Volume: 12, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; beta-Endorphin; Eating; Endorphins; Enkephalin, Methionine; Female; Immune System; Lymphocyte Activation; Mammary Neoplasms, Experimental; Naltrexone; Neurosecretory Systems; Prolactin; Rats; Rats, Inbred F344; Stress, Physiological

1991